User Fee Revenue Sums Would Be Unknown By FDA Under House Proposal
This article was originally published in The Gray Sheet
Executive Summary
A FDL-1bill pending in the House Energy & Commerce Committee would allocate all FDA user fee revenue to a general Treasury fund